Future Vaccine Development May Be Inspired by New Research Findings Scientists at Boston Children's Hospital have created an antibody, SP1-77, that successfully neutralizes all tested SARS-CoV-2 variants, including Omicron. Unlike traditional antibodies, SP1-77 prevents the virus from fusing with c
scitechdaily.com